Retirement Group’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$10.1K Sell
500
-200
-29% -$4.61K ﹤0.01% 473
2023
Q4
$15.8K Buy
+700
New +$14.8K 0.01% 378
2022
Q4
Sell
-760
Closed -$32K 711
2022
Q3
$32K Buy
760
+735
+2,940% +$19.9K 0.03% 148
2022
Q2
$1K Sell
25
-1,250
-98% -$31.6K ﹤0.01% 703
2022
Q1
$47K Buy
1,275
+60
+5% +$2.54K 0.02% 239
2021
Q4
$53K Buy
1,215
+165
+16% +$8.65K 0.02% 223
2021
Q3
$65K Buy
+1,050
New +$87.6K 0.03% 201

Other funds holding FLNA

Retirement Group's FLNA Position: Q1 2024 in Review

Retirement Group reduced its Filana Therapeutics (FLNA) stake by 29% in Q1 2024, selling an estimated $4.61K and leaving 500 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Retirement Group first reported a position in FLNA in Q3 2021 and has held it in 7 quarters since. The position peaked at $65K in Q3 2021. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Retirement Group held 500 shares of Filana Therapeutics worth $10.1K as of Q1 2024.
  • Retirement Group sold 200 Filana Therapeutics shares in Q1 2024, an estimated $4.61K.
  • Filana Therapeutics made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #473 holding.
  • Retirement Group first reported a position in Filana Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • Retirement Group's Filana Therapeutics position peaked at $65K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.